Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDeration
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
A multicentre observational study on treatment patterns and ctDNA HRR evaluation in aggressive high-volume metastatic hormone-sensitive prostate cancer in Russian Federation
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Mężczyźni w wieku 18 lat i starsi
- •Podpisana zgoda na udział w badaniu i pobranie próbek krwi
- •Zaawansowany rak prostaty wrażliwy na hormony (nowy lub zaawansowany z wcześniejszych stadiów)
- •Agresywna postać choroby (stopień Gleasona 8-10)
- •Rozległa choroba przerzutowa (4 lub więcej przerzutów w kościach, w tym poza kręgosłupem/miedznicą, lub 1 przerzut w narządach)
- •Dostęp do dokumentacji medycznej pacjenta
- •Znany status zmian genetycznych z poprzedniego badania próbki guza
✗ Disqualifies
- •Uczestnictwo w innym badaniu klinicznym od czasu rozpoznania zaawansowanego raka prostaty
- •Progresja do opornego na hormony raka prostaty
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 10, 2026
- Sex
- Male only
Locations (26)
Research Site
Arkhangelsk, Russia
Research Site
Barnaul, Russia
Research Site
Chelyabinsk, Russia
Research Site
Irkutsk, Russia
Research Site
Kazan', Russia
Research Site
Krasnodar, Russia
Research Site
Krasnoyarsk, Russia
Research Site
Moscow, Russia
Research Site
Moscow, Russia
Research Site
Moscow, Russia
Research Site
Nal'chik, Russia
Research Site
Nizhny Novgorod, Russia
Research Site
Obninsk, Russia
Research Site
Omsk, Russia
Research Site
Pskov, Russia
Research Site
Saint Petersburg, Russia
Research Site
Saint Petersburg, Russia
Research Site
Saransk, Russia
Research Site
Sochi, Russia
Research Site
Syktyvkar, Russia
Research Site
Tomsk, Russia
Research Site
Tomsk, Russia
Research Site
Tver', Russia
Research Site
Tyumen, Russia
Research Site
Ufa, Russia
Research Site
Yekaterinburg, Russia
Trial contact
AstraZeneca Clinical Study Information Center
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/11/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.